205 related articles for article (PubMed ID: 33931028)
21. Coupling Dichloroacetate Treatment with Curcumin Significantly Enhances Anticancer Potential.
Kan PC; Chang YJ; Chien CS; Su CY; Fang HW
Anticancer Res; 2018 Nov; 38(11):6253-6261. PubMed ID: 30396945
[TBL] [Abstract][Full Text] [Related]
22. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells.
Choi YW; Lim IK
Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191
[TBL] [Abstract][Full Text] [Related]
23. Targeting HIF-1α is a prerequisite for cell sensitivity to dichloroacetate (DCA) and metformin.
Hong SE; Jin HO; Kim HA; Seong MK; Kim EK; Ye SK; Choe TB; Lee JK; Kim JI; Park IC; Noh WC
Biochem Biophys Res Commun; 2016 Jan; 469(2):164-70. PubMed ID: 26616058
[TBL] [Abstract][Full Text] [Related]
24. Dual-targeting of aberrant glucose metabolism in glioblastoma.
Shen H; Decollogne S; Dilda PJ; Hau E; Chung SA; Luk PP; Hogg PJ; McDonald KL
J Exp Clin Cancer Res; 2015 Feb; 34(1):14. PubMed ID: 25652202
[TBL] [Abstract][Full Text] [Related]
25. Dichloroacetate enhances adriamycin-induced hepatoma cell toxicity in vitro and in vivo by increasing reactive oxygen species levels.
Dai Y; Xiong X; Huang G; Liu J; Sheng S; Wang H; Qin W
PLoS One; 2014; 9(4):e92962. PubMed ID: 24728083
[TBL] [Abstract][Full Text] [Related]
26. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
Cells; 2019 May; 8(5):. PubMed ID: 31109089
[TBL] [Abstract][Full Text] [Related]
27. A potent tumoricidal co-drug 'Bet-CA'--an ester derivative of betulinic acid and dichloroacetate selectively and synergistically kills cancer cells.
Saha S; Ghosh M; Dutta SK
Sci Rep; 2015 Jan; 5():7762. PubMed ID: 25585916
[TBL] [Abstract][Full Text] [Related]
28. Influence of dichloroacetate (DCA) on lactate production and oxygen consumption in neuroblastoma cells: is DCA a suitable drug for neuroblastoma therapy?
Niewisch MR; Kuçi Z; Wolburg H; Sautter M; Krampen L; Deubzer B; Handgretinger R; Bruchelt G
Cell Physiol Biochem; 2012; 29(3-4):373-80. PubMed ID: 22508045
[TBL] [Abstract][Full Text] [Related]
29. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.
Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
Br J Cancer; 2010 Jun; 102(12):1746-52. PubMed ID: 20485289
[TBL] [Abstract][Full Text] [Related]
30. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
31. Dichloroacetate induces autophagy in colorectal cancer cells and tumours.
Lin G; Hill DK; Andrejeva G; Boult JK; Troy H; Fong AC; Orton MR; Panek R; Parkes HG; Jafar M; Koh DM; Robinson SP; Judson IR; Griffiths JR; Leach MO; Eykyn TR; Chung YL
Br J Cancer; 2014 Jul; 111(2):375-85. PubMed ID: 24892448
[TBL] [Abstract][Full Text] [Related]
32. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
33. Dichloroacetate metabolically targeted therapy defeats cytotoxicity of standard anticancer drugs.
Heshe D; Hoogestraat S; Brauckmann C; Karst U; Boos J; Lanvers-Kaminsky C
Cancer Chemother Pharmacol; 2011 Mar; 67(3):647-55. PubMed ID: 20502900
[TBL] [Abstract][Full Text] [Related]
34. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis.
Chong D; Ma L; Liu F; Zhang Z; Zhao S; Huo Q; Zhang P; Zheng H; Liu H
Anticancer Drugs; 2017 Sep; 28(8):831-840. PubMed ID: 28816773
[TBL] [Abstract][Full Text] [Related]
35. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.
Xie J; Wang BS; Yu DH; Lu Q; Ma J; Qi H; Fang C; Chen HZ
Int J Oncol; 2011 Feb; 38(2):409-17. PubMed ID: 21132264
[TBL] [Abstract][Full Text] [Related]
36. Methylglyoxal in combination with 5-Fluorouracil elicits improved chemosensitivity in breast cancer through apoptosis and cell cycle inhibition.
Ghosh S; Pal A; Ray M
Biomed Pharmacother; 2019 Jun; 114():108855. PubMed ID: 31003140
[TBL] [Abstract][Full Text] [Related]
37. Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway.
Huang YF; Zhu DJ; Chen XW; Chen QK; Luo ZT; Liu CC; Wang GX; Zhang WJ; Liao NZ
Oncotarget; 2017 Jun; 8(25):40264-40275. PubMed ID: 28402965
[TBL] [Abstract][Full Text] [Related]
38. Dichloroacetate induces apoptosis in endometrial cancer cells.
Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the hyaluronan matrix enhances metabolic anticancer therapy by dichloroacetate in vitro and in vivo.
Twarock S; Reichert C; Bach K; Reiners O; Kretschmer I; Gorski DJ; Gorges K; Grandoch M; Fischer JW
Br J Pharmacol; 2019 Dec; 176(23):4474-4490. PubMed ID: 31351004
[TBL] [Abstract][Full Text] [Related]
40. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
Mei L; Chen Y; Wang Z; Wang J; Wan J; Yu C; Liu X; Li W
Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
